Rexulti 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FWY46
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,895
Award facts
- Contract value 100% obligated
- $5,894.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count) valued at $5,894.80 under a firm fixed-price contract, with performance through August 21, 2025. This non-set-aside award was issued on August 20, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in treating schizophrenia and major depressive disorder, reflecting DLA's ongoing pharmaceutical supply requirements for military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime pharmaceutical supply vehicle that runs through December 2026. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen supplies a comprehensive range of medications and medical products to support Defense Health Agency operations and other federal healthcare systems globally. The company's competitively awarded contracts with DLA demonstrate its capability to meet critical pharmaceutical supply needs across multiple therapeutic domains for military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FWY46?
SPE2DB25FWY46 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FWY46 worth?
The government has obligated $5,895 on SPE2DB25FWY46.
Is contract SPE2DB25FWY46 an order under another contract?
Yes. SPE2DB25FWY46 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWY46 competed?
The extent of competition for SPE2DB25FWY46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award